Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Clinical trial NCT01119105 · COMPLETED
Trial details
- NCT number
- NCT01119105
- Sponsor
- Nabriva Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-12-31
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.